During recent years it has become clear that the capacity of albumin to bind bilirubin is limited. Most authors agree that one molecule of albumin can only bind tightly one molecule of bilirubin (Odell, 1959; Bjerrum, 1968; Jacobsen, 1969; Bratlid and Fog, 1970; Lie and Bratlid, 1970) . Though additional bilirubin molecules may be bound to secondary sites on the albumin molecule, these molecules seem to be as toxic or even more toxic to cells as unbound bilirubin (Bratlid and Rugstad, 1972) .
Several published reports show, however, that kernicterus may occur in infants with bilirubin concentrations far below the binding capacity of the high affinity albumin site (Harris, Lucey, and MacLean, 1968; Gartner et al., 1970) . This can be explained by the competitive binding of several other substances on the albumin molecule (Odell, 1959; Bratlid, 1972c, d) , and low pH has also been found to reduce the binding of bilirubin to albumin (Odell, 1965; Bratlid, 1972b) . A determination of the real binding capacity of albumin for bilirubin is therefore needed, and for this purpose several methods have been described based on the competitive binding between bilirubin and other Received 18 August 1972. compounds for the albumin molecule (Waters and Porter, 1961; Porter and Waters, 1966; Odell, Cohen, and Kelly, 1969; Howorth, 1971) .
It is known that bilirubin is also bound to erythrocytes (Watson, 1962; Oski and Naiman, 1963) , and it has been shown that this binding is markedly increased if there is a reduction in the capacity of albumin to bind bilirubin (Bratlid, 1972b, c, d ).
Measurement of this fraction of the total blood bilirubin might therefore serve as an indicator of the degree of saturation of the albumin molecule with bilirubin.
In the present report the amount of red cell bound bilirubin in cases of neonatal jaundice has been compared with the reserve HBABA (2(4' hydroxyazobenzene) benzoic acid) binding capacity (Porter and Waters, 1966) and the salicylate saturation index (Odell et al., 1969 in the dark at -15 'C. The indications for exchange transfusions were as described by Aagenaes (1967) .
Determination of erythrocyte-bound bilirubin was performed as described elsewhere (Bratlid, 1972a) . 1 ml whole blood was washed three times in isotonic phosphate buffer-glucose pH 7*4 and the bilirubin bound by the cells was eluted by incubating the cells for 15 minutes in 2 ml of a 3 g/100 ml solution of human albumin in phosphate buffer pH 7-4. After centrifugation the bilirubin concentration was determined in the supematant, and the amount of bilirubin bound by the cells calculated from this and the haematocrit.
HBABA (2(4'hydroxyazobenzene) benzoic acid) binding capacity was determined as described by Porter and Waters (1966) , using a 4 g/100 ml solution of albumin as reference.
The salicylate saturation index (SI) was determined as described by Odell et al. (1969) .
Albumin concentrations were determined by radioimmunodiffusion (Partigen, Behringwerke). Bilirubin was determined by a modification of the method of Jendrassik and Grof (Fog, 1958) .
Bilirubin was obtained from Koch-Light Laboratories. Albumin was obtained from Kabi, Sweden.
Spectrophotometric absorption curves were obtained using a Beckman DK-2A automatic spectrophotometer.
105 sera from 72 patients with neonatal jaundice were analysed. 5 samples were from patients with jaundice not related to haemolytic disease.
Results
Total plasma bilirubin concentration varied from 2-2 to 32-0 mg/100 ml with a mean of 12-5 mg/ 100 ml. Albumin concentrations varied from 2 0 to 4 3 g/100 ml with a mean of 3 2 g/100 ml.
Red cell bilirubin varied between 0 3 mg/100 ml and 6 1 mg/100 ml Two of the samples showed a much higher erythrocytic binding of bilirubin than all the others with levels of 6 -1 and 4 * 4 mg/100 ml, respectively. Both these patients had plasma bilirubin/albumin molar ratios above unity, and at the time of sampling showed signs of bilirubin encephalopathy. The patient with a red cell binding of bilirubin of 6 1 mg/100 ml later died, and kernicterus was confirmed at necropsy. The other patient improved after albumin administration and several exchange transfusions. 2 months after discharge from hospital the infant's neurological status was not known. Fig. 1 shows that a correlation exists between the amount of red cell bound bilirubin and the molar bilirubin/albumin ratio in the plasma samples, as would be expected from in vitro experiments (Bratlid, 1972a) .
The HBABA binding capacity of the plasma samples is shown in Fig. 2 . The values ranged from 6 to 92. Two samples showed a reserve dye-binding capacity below 25, which most authors consider is indicative of the development of kernicterus (Porter and Waters, 1966; Priolisi and Ziino, 1971) . These patients had, however, no special clinical signs of bilirubin encephalopathy, and their serum bilirubin concentrations were only moderately raised, 7-1 and 15 mg/100 ml, respectively, with correspondingly low plasma bilirubin/ albumin ratios. On the other hand, the 2 patients with clinical signs of bilirubin encephalopathy had HBABA values which were not significantly lower than those of other patients. The salicylate saturation index (SI) of the plasma samples is shown in Fig. 2 . The values varied from 0 * 2 to 20 * 7. No correlation was found between the SI and the molar bilirubin/albumin ratio of the samples. This is in agreement with the findings of Odell et al. (1969) for samples from patients with haemolytic disease. 48 of the samples had SI values above 8, suggesting that these patients were likely to develop bilirubin encephalopathy (Odell et al., 1969) . This is in sharp contrast to the observation that only two patients were at risk judged by the HBABA method, and that of these two patients only one also had high SI. Moreover, the two patients with clinical (Fig. 1) . This is in agreement with earlier in vitro studies (Kaufmann, Simcha, and Blondheim, 1967; Bratlid, 1972a) , though the wide scatter of the results suggests that several other factors also influence the binding of bilirubin.
The only 2 patients with bilirubin encephalopathy at the time of sampling had values for red cell bilirubin which were well above those found in the other patients. With (Fig. 2) . On the other hand, several authors have reported the HBABA binding tests to be useful (Porter and Waters, 1966; Priolisi and Ziino, 1971; Svenningsen, Lindquist, and Dahlquist, 1971) , though some variation exists between the HBABA binding value which is considered to be indicative of risk for bilirubin encephalopathy. It has, however, been shown (Priolisi and Ziino, 1971) (Fig. 2) . As mentioned, 48 of the samples had SI values above 8, suggesting that these patients were likely to develop bilirubin encephalopathy. In addition, 5 samples, mostly with low plasma bilirubin concentrations, showed SI values above 14, which has been given as the highest value obtainable in this test, indicating complete saturation of the albumin molecule (Odell et al., 1969) . However, the basis for this method is measurement of the spectrophotometric differences which exist between bilirubin bound to albumin and unbound bilirubin at pH 7 * 4. This is based on two assumptions. Firstly, it implies that unbound bilirubin should exist as such at pH 7-4 in high enough concentrations for spectrophotometric registrations, and secondly, that salicylate displaces bilirubin completely from the albumin molecule. Both of these assumptions may be wrong.
Firstly, the extremely low solubility of bilirubin at physiological pH (Brodersen and Theilgaard, 1969) makes it impossible for bilirubin to exist unbound in solution in any significant concentration; crystallization will rapidly take place (Brodersen and Theilgaard, 1969; Bratlid and Fog, 1970) . As shown in Fig. 3 and also reported earlier by others (Bratlid and Fog, 1970; Brodersen et al., 1972) , this crystallization is reflected by a drop in maximum optical density and an increase in absorbance at wave lengths above 500 nm. The group.bmj.com on April 11, 2017 -Published by http://adc.bmj.com/ Downloaded from absorbance curves for unbound bilirubin given by Odell et al. (1969) are much like the 5-minute curve in Fig. 3 Brodersen (1972) , salicylate seems to displace bilirubin from the primary binding site onto the secondary binding sites with the successive formation of bilirubin-albumin co-crystals composed of approximately 200 mol bilirubin per mol albumin. Bilirubin molecules bound to secondary sites on the albumin molecule, though very unstable, seem to have a higher maximum optical density and at a slightly higher wavelength than when bound at the primary site (Bratlid and Fog, 1970; Brodersen et al., 1972) , in fact, almost the opposite spectral changes to the reference curve given for the saturation index method (Odell et al., 1969) . Even if this curve should be useful as a curve for unbound bilirubin, as doubted above, it can therefore probably not be used as a reference for the effect of salicylate displacement of bilirubin since addition of salicylate does not give unbound bilirubin. Until 
